Evidence map›Paper›PMID 41274883›Full record

ArticleSchizophrenia (Heidelberg, Germany)2025

How researchers refer to individuals with schizophrenia: person-first and identity-first language in academic papers.

Maria Dino, Gabriela Koga, Amanda Yokoji, Bernardo Haguiara, Isadora Pacheco, Carolina Ziebold, Rodrigo Bressan, Nicolas Crossley, José Orsi, Graham Thornicroft and 5 more

Abstract read
In one paragraph

Article in Schizophrenia (Heidelberg, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Maria Dino *Interdisciplinary Laboratory in Clinical Neuroscience (LiNC), Department of Psychiatry, Escola Paulista de Medicina, Universidade Federal de São Paulo (EPM/UNIFESP), São Paulo, Brazil.
Gabriela Koga *Interdisciplinary Laboratory in Clinical Neuroscience (LiNC), Department of Psychiatry, Escola Paulista de Medicina, Universidade Federal de São Paulo (EPM/UNIFESP), São Paulo, Brazil.ORCID http://orcid.org/0000-0002-6093-0918
Amanda YokojiInterdisciplinary Laboratory in Clinical Neuroscience (LiNC), Department of Psychiatry, Escola Paulista de Medicina, Universidade Federal de São Paulo (EPM/UNIFESP), São Paulo, Brazil.
Bernardo HaguiaraInterdisciplinary Laboratory in Clinical Neuroscience (LiNC), Department of Psychiatry, Escola Paulista de Medicina, Universidade Federal de São Paulo (EPM/UNIFESP), São Paulo, Brazil.ORCID http://orcid.org/0000-0003-1211-9140
Isadora PachecoInterdisciplinary Laboratory in Clinical Neuroscience (LiNC), Department of Psychiatry, Escola Paulista de Medicina, Universidade Federal de São Paulo (EPM/UNIFESP), São Paulo, Brazil.
Carolina ZieboldInterdisciplinary Laboratory in Clinical Neuroscience (LiNC), Department of Psychiatry, Escola Paulista de Medicina, Universidade Federal de São Paulo (EPM/UNIFESP), São Paulo, Brazil.
Rodrigo BressanInterdisciplinary Laboratory in Clinical Neuroscience (LiNC), Department of Psychiatry, Escola Paulista de Medicina, Universidade Federal de São Paulo (EPM/UNIFESP), São Paulo, Brazil.ORCID http://orcid.org/0000-0002-0868-4449
Nicolas CrossleyDepartment of Psychiatry, School of Medicine. Pontificia Universidad Católica de Chile, Santiago, Chile.ORCID http://orcid.org/0000-0002-3060-656X
José OrsiSchizophrenia Program, Department of Psychiatry, Escola Paulista de Medicina, Universidade Federal de São Paulo (PROESQ - EPM/UNIFESP), São Paulo, Brazil.
Graham ThornicroftCentre for Global Mental Health and Centre for Implementation Science, Health Service and Population Research Department, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, United Kingdom.
Mike SladeSchool of Health Sciences, University of Nottingham, Nottingham, UK.
Jair de Jesus MariSchizophrenia Program, Department of Psychiatry, Escola Paulista de Medicina, Universidade Federal de São Paulo (PROESQ - EPM/UNIFESP), São Paulo, Brazil.ORCID http://orcid.org/0000-0002-5403-0112
Sara Evans-LackoCare Policy and Evaluation Centre, London School of Economics and Political Science, London, UK.
Mário César Rezende AndradeDepartment of Psychology, Universidade Federal de São João del-Rei (UFSJ), São João del-Rei, Brazil.ORCID http://orcid.org/0000-0003-2784-5209
Ary GadelhaInterdisciplinary Laboratory in Clinical Neuroscience (LiNC), Department of Psychiatry, Escola Paulista de Medicina, Universidade Federal de São Paulo (EPM/UNIFESP), São Paulo, Brazil. ary.araripe@unifesp.br.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Stigma associated with schizophrenia has been well-documented in both society and healthcare settings. However, the use of stigmatizing language in research papers remains largely unexplored. This study examined how researchers refer to schizophrenia in peer-reviewed articles, aiming to characterize the descriptive terms used to refer to individuals with schizophrenia and assess the adoption of person-first language. We conducted an electronic search on PubMed using the MeSH term "schizophrenia" and randomly selected 500 articles. Descriptive terminology was categorized as neutral (e.g., "schizophrenia patients"), person-first (e.g., "person with schizophrenia"), or identity-first (e.g., "schizophrenic patient"). Reference terms were assessed based on their alignment with a person-first perspective. Of the 500 studies, 475 (95%) included at least one term referring to people affected by schizophrenia. Among them, 238 (50.1%) used identity-first terms, 228 (48%) used person-first terms, and 91 (18.2%) employed both. Over time, the use of identity-first terms decreased. The decline in identity-first terms over time suggests a positive impact of the person-first movement. Despite these encouraging findings, our data also indicate that there is still room for improvement in reducing the use of identity-first terms. We propose recommendations for researchers to promote less stigmatizing language.

Identifiers

PMID41274883
PMCPMC12663300

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.